Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the US.1,2 More than 11 million Americans have it and millions more may have it without knowing it.1,2
Learn how you can help ease the burden of COPD while earning CME credit. Updates on NIV in COPD is offered by Medscape Education Critical Care and is supported by an independent educational grant from ResMed.* In this course, Dr. Criner and Dr. Hill will:
Upon course completion, you will understand the evidence base of NIV use in patients with severe COPD, be able to identify COPD patients who are long-term NIV candidates and earn 0.5 AMA PRA Category 1 Credit™.
Course moderator: Gerard J. Criner, MD
Professor and Chair, Thoracic Medicine and Surgery
Lewis Katz School of Medicine
Director, Temple Lung Center
Course discussant: Nicholas S. Hill, MD
Chief, Pulmonary, Critical Care and Sleep Division
Tufts University School of Medicine
* Medscape is a free educational resource. However, if you are not already a Medscape member, you will be asked to register with a self-selected username and password.
1 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2017 Report. GOLD; 2017.
2 American Lung Association. How Serious is COPD. http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/learn-about-copd/how-serious-is-copd.html. Approved by Scientific and Medical Editorial Review Panel. Last reviewed December 18, 2017.
AMA PRA Category 1 Credit™ is a trademark of the American Medical Association, registered in the U.S. and other countries. The Medscape logo is a trademark of WebMD LLC, registered in the U.S. and other countries.